The optimal 18F-fluoromisonidazole PET threshold to define tumor hypoxia in preclinical squamous cell carcinomas using pO2 electron paramagnetic resonance imaging as reference truth
Authors:
- 6 July 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (12) , 4014-4024
Abstract
Purpose To identify the optimal threshold in 18F-fluoromisonidazole (FMISO) PET images to accurately locate tumor hypoxia by using electron paramagnetic resonance imaging (pO2 EPRI) as ground truth for hypoxia, defined by pO2 \(\le\) 10 mmHg. Methods Tumor hypoxia images in mouse models of SCCVII squamous cell carcinoma (n = 16) were acquired in a hybrid PET/EPRI imaging system 2 h post-injection of FMISO. T2-weighted MRI was used to delineate tumor and muscle tissue. Dynamic contrast enhanced (DCE) MRI parametric images of Ktrans and ve were generated to model tumor vascular properties. Images from PET/EPR/MRI were co-registered and resampled to isotropic 0.5 mm voxel resolution for analysis. PET images were converted to standardized uptake value (SUV) and tumor-to-muscle ratio (TMR) units. FMISO uptake thresholds were evaluated using receiver operating characteristic (ROC) curve analysis to find the optimal FMISO threshold and unit with maximum overall hypoxia similarity (OHS) with pO2 EPRI, where OHS = 1 shows perfect overlap and OHS = 0 shows no overlap. The means of dice similarity coefficient, normalized Hausdorff distance, and accuracy were used to define the OHS. Monotonic relationships between EPRI/PET/DCE-MRI were evaluated with the Spearman correlation coefficient (\(\rho\)) to quantify association of vasculature on hypoxia imaged with both FMISO PET and pO2 EPRI. Results FMISO PET thresholds to define hypoxia with maximum OHS (both OHS = 0.728 \(\pm\) 0.2) were SUV \(\ge\) 1.4 \(\times\) SUVmean and SUV \(\ge\) 0.6 \(\times\) SUVmax. Weak-to-moderate correlations (|\(\rho\)|< 0.70) were observed between PET/EPRI hypoxia images with vascular permeability (Ktrans) or fractional extracellular-extravascular space (ve) from DCE-MRI. Conclusion This is the first in vivo comparison of FMISO uptake with pO2 EPRI to identify the optimal FMISO threshold to define tumor hypoxia, which may successfully direct hypoxic tumor boosts in patients, thereby enhancing tumor control.
Keywords
All Related Versions
Funding Information
- National Cancer Institute (F31 CA254223, R01 CA098575, R01 CA 236385, P30 CA014599)
- National Institute of Biomedical Imaging and Bioengineering (P41 EB002034)
- National Institutes of Health (S10 OD025265, R01 EB029948)
This publication has 36 references indexed in Scilit:
- Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistanceRadiotherapy and Oncology, 2011
- Hypoxia-Induced Angiogenesis: Good and EvilGenes & Cancer, 2011
- Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative StressRadiation Research, 2009
- Molecular Imaging of HypoxiaJournal of Nuclear Medicine, 2008
- Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy responseNature Reviews Cancer, 2008
- Electron Paramagnetic Resonance Oxygen Image Hypoxic Fraction Plus Radiation Dose Strongly Correlates With Tumor Cure in FSa FibrosarcomasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Hypoxic Radiosensitization: Adored and IgnoredJournal of Clinical Oncology, 2007
- A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxiaPhysics in Medicine & Biology, 2005
- Basic principles of ROC analysisSeminars in Nuclear Medicine, 1978
- The action of radium on cancer cells. II.—Some factors determining the susceptibility of cancer cells to radiumProceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1933